Saturday, June 21, 2025
27.6 C
Bengaluru

Specially Designed Case Study based Modules for Pharma Marketing Professionals

DEPA 2.0 Workshop – Open to participants from all companies – Starting February 5th, 2022.

We can also conduct a customized workshop to address your company’s specific needs on dates and timelines convenient to you.

The 4- Module Workshop series will be moderated by Anup Soans with international and Indian faculty – Dr. Peter Velev, a medical doctor and pharma industry veteran, and Salil Kallianpur, pharma marketing veteran and digital brand coach.

Objective: More than digitalizing your product promotions, the case calls for building and engaging your brand community through digital solutions that create memorable customer experiences.

With the new normal emerging, the traditional Pharma commercial model needs to be relooked by exploring alternative channels of engagement, which offer opportunities to create value for customers.

Company-specific digital adoption workshops to experience how a brand can be promoted using the omnichannel approach with field force involvement.

Interactive Webinars extended with Virtual Event – 4 Modules – 2.0 hours each over 4 weeks.

Register Now – https://medicinman.weslamdunk.com/depa20-request-payment-link/register-for-depa-2-0/

https://medicinman.weslamdunk.com/depa20-request-payment-link/register-for-depa-2-0/

Hot this week

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the...

Topics

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the...

Indian Pharma Market (IPM) Highlights – January 2025

Overall IPM Performance: Monthly Growth: IPM monthly growth reached 8.4% in...

Role of AI Across Pharma Industry

Introduction Artificial intelligence (AI) is increasingly pivotal in driving innovation...
spot_img

Related Articles

spot_imgspot_img